Tuesday, 19 May 2020

Analysis on Veterinary Pain Management Market Forecast to 2027

Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Market Highlights:
Veterinary Pain Management Market Size is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.
Veterinary Pain Management Market   - Segmentations
MRFR has segmented the analysis into seven key dynamics for better understanding: -
By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World.
Veterinary Pain Management Market   - Geographical Analysis
The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 
Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.
Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.
The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.
The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.
Veterinary Pain Management Market   - Competitive Landscape
The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.
Key Players:
Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.
Industry/ Innovation/ Related News:
November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels:

Analysis and Growth on Aromatherapy Market size, Share Trends and Forecast

Market Scenario
Market Research Future (MRFR) postulates that the aromatherapy market is estimated to garner USD 4.3 billion, grabbing a healthy CAGR of 6.18 % during the forecast period (2017-2023). The non-invasive nature of aromatherapy is encouraging the market growth. Aromatherapy is practiced across the globe to treat several conditions like burns, eczema, acne, skin rashes, etc. and is also being gradually approved for pain management. Aromatherapy is common among the geriatric population as they help to heal chronic pain. The procedure is progressively being used at homes for instant relief from cold and flu, relaxation and sleep, mood enhancement, and pain relief. They are cost-effective, offer privacy and convenience. Aromatherapy finds application in the skin and hair care, relaxation, cold and cough, pain management, scar management, insomnia, and others.
Market Potential and Pitfalls
The aromatherapy market is experiencing an up thrust across the globe with a large number of the global population opting for aromatherapy, non-invasive nature of aromatherapy, and increasing lifestyle industry. The modern lifestyle is encircled with problems such as stress and sleep disturbances which have further inflated the market growth. Aromatherapy used aromatic and other essential oils which helps to combat cold, increase immunity and improve breathing disorders. Such benefits have encouraged the aromatherapy market worldwide. The surging practice of aromatherapy at home, growing customer fondness towards the use of natural products, and the high prevalence of lifestyle diseases are likely to propel the market growth in the coming years.
Essential oils used in aromatherapy possess several natural healing factors. Therapeutic grade essential oils have a positive impact on the overall wellness of the patient. They are considered a natural cleanser and also an antibacterial remedy when ingested. Moreover, people across the globe are becoming aware of the benefits provided by such natural therapies, which is further encouraging the market growth. Consumers are buying cosmetic products integrated with aromatherapy ingredients and essential oils. Aromatherapy products including and creams, bath salts, and massage oils are popular among the consumers. Manufacturers are thus offering a varied range of aromatherapy consumables which consist of natural ingredients, pleasant smell, and relaxing properties. Oils such as lavender, lemongrass, and peppermint are gaining huge prominence among the manufactures. Such factors are influencing the growth of the aromatherapy market across the globe.
On the contrary, the toxic nature of the essential oils and a dearth of proper guidelines are considered some of the top barriers vitiating the market growth across the globe. For instance, Cineole is an essential oil which can be poisonous above the recommended dose. An overdose can cause nausea, epigastric burning, dizziness, vomiting, rapid heartbeat, muscular weakness, feeling of suffocation, etc.
Global Aromatherapy Market: Segmental Analysis
The global aromatherapy market has been segmented on the basis of product, application, and therapeutic application.
By mode of product, the global aromatherapy market has been segmented into essential oils and equipment. Among these, the essential oils segment is likely to gain prominence in the coming years owing to the increased awareness regarding the therapeutic value of these oils.
By mode of application, the global aromatherapy market has been segmented into inhalation, tropical, and aerial diffusion.
By mode of therapeutic application, the global aromatherapy market has been segmented into relaxation and sleep, skin and hair care, pain management, and other remedies. Among these, the relaxation & sleep segment is considered to gain prominence in the coming years owing to the surging number of people suffering from stress and anxiety along with the side effects associated with alternative medicines.
Regional Insights
Geographically, the aromatherapy market span across regions namely, Europe, North America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, the North American region is the most prominent region in the global market with the U.S. generating the maximum revenue. The high per capita income and high population density are the top two factors encouraging the market growth in this region. The surging awareness among the people regarding the health benefits of essential oils and aromatherapy coupled with the rising demand for herbal products for personal care are contributing to the growth of the market.
The European region is estimated to occupy the second spot and is likely to expand at the fastest speed. France is considered the largest market in this region owing to the tradition of aromatics. The presence of prominent market players has further influenced the market growth.
The Asia Pacific region is experiencing steady growth with China being the largest market owing to the presence of a large population. The region has proved to be a potential region for the market players owing to the surging incidences of lifestyle and chronic diseases, high population base, and growing disposable income of the people. Medical tourism makes the region a lucrative region for aromatherapy as economies like India having the traditional process of using natural resources and essential oils for treating various illness attract tourists across the globe.
Industry Updates
March 27, 2019: Lunaroma Aromatic Apothecary in Burlington offer over hundreds of essential oils and they are now making their way into modern medicine with doctors using the age-old technique to help their patients.
Competitive Dashboard
The prominent players operating the global aromatherapy market comprises NOW Foods, Muji, Tree of Life, Young Living, Neal’s Yard Remedies, dōTERRA, Zija International, Nu Skin, Air Aroma, and others.
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels:

Monday, 18 May 2020

booming Topic of Swollen Knee Treatment Market with Segmentation and Regional Analysis

Market Analysis 
The global swollen knee treatment market is likely to grow at a notable CAGR between 2018- 2023, reveals the new Market Research Future (MRFR) report. Knee swelling, or what is also occasionally known as “water on the knee” occurs for the accumulation of surplus fluid in and around the knee joints. In medical terms, this condition is called “knee effusion”. Swelling in the knee can result on account of injuries like broken bones, cartilage tear, or torn ligament. Surgery, liposomal bupivacaine, nerve blocks, patient-controlled analgesia (PCA) pumps, and medications, are some of the different types of swollen knee treatment. 
Various factors are adding to the swollen knee treatment market share. Such factors, as revealed by the latest MRFR report, include rising prevalence of arthritis, obesity, sports-related injuries, diabetes, and osteoporosis, an increase in the geriatric population, rising cases of musculoskeletal diseases, and an increasing number of surgeries being undertaken. 
On the contrary, financial slowdown, huge surgical cost, intense competition, and increasing awareness about non-surgical treatment like painkiller medicines, weight loss programs, walking aids, shoe inserts, and exercises are factors that may limit the swollen knee treatment market growth over the forecast period. Besides knee joint infections and complications may also restrict the market growth.
Market Segmentation
The Market Research Future Report provides an inclusive segmental analysis of the global swollen knee treatment market size based on end users and type. 
By type, the swollen knee treatment market is segmented into surgery, liposomal bupivacaine, nerve blocks, patient-controlled analgesia (PCA) pumps, and medications. Medications are again segmented into corticosteroids and opioids, and others. Surgery is again segmented into knee replacement, arthroscopy, and arthrocentesis. Knee replacement is again segmented into unicompartmental knee replacement, total knee replacement, and others. 
By end users, the swollen knee treatment market is segmented into ambulatory surgery centers, clinics, hospitals, and others. 
Regional Analysis 
By region, the global swollen knee treatment market report covers the growth opportunities and recent trends across North America, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, North America will dominate the market over the forecast period. Factors propelling the swollen knee treatment market growth in the region include favorable compensation setting for several surgical procedures, growing healthcare sector, increasing awareness, and early adoption of advanced medical technologies. 
 The swollen knee treatment market in Europe is predicted to hold the second-largest share during the forecast period. Factors propelling the swollen knee treatment market growth in the region include growing demand for advanced treatment procedures, the rising number of surgeries, and the growing frequency of diabetes patients in the region. 
The swollen knee treatment market in the APAC region is predicted to grow at a fast pace over the forecast period. Factors propelling the swollen knee treatment market growth in the region include rising medical tourism, increasing disposable income, better adoption rate, burgeoning demand for advanced technology, and access to optimal treatment facilities. 
The swollen knee treatment market in the MEA will have a small share over the forecast period due to poor medical facilities, a lack of technical knowledge, and an underdeveloped healthcare sector. 
Key Players
Key players profiled in the global swollen knee treatment market report include Smiths Medical, Teleflex, C.R.Bard, AngioDynamics, Fresenius Kabi, Merck & Co., Pfizer Pharmaceuticals Inc., B. Braun Melsungen AG, Exactech, Biomet Inc., Wright Medical Group Inc., DePuy Companies Inc., Smith & Nephew Plc., Zimmer Holdings, and Stryker Corporation. Industry players have incorporated several strategies to stay head and shoulders above others in the completion and also cater to the growing needs of consumers. Some of these strategies include contracts, joint ventures, collaborations, strategic alliances, mergers and acquisitions, product launches, and others. 
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

Attractive Market Opportunities in Medication Management Market Grow at a significant rate

The global medication management market size is expected to exhibit a strong 13.4% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global medication management market is mainly driven by the growing geriatric population and the growing awareness about medication management, which has led to a raft of new products in the market. The report assesses the probabilities of the market’s various growth trajectories through the 2018-2023 forecast period and delivers a detailed analysis of the market’s major growth drivers and restraints. The leading factors enabling growth of the medication management market are assessed in detail in the report. The major restraints hampering the market growth are also profiled in the report, providing a complete overview of the market. The leading players operating in the global medication management market are also profiled in the report, providing readers with a complete overview of the competitive landscape of the market. 
Medication management is a key part of healthcare services and tracks medication from its acquisition in hospitals to its consumption by the patient. The medication management market has emerged as a major part of the healthcare sector mainly due to the growing geriatric population around the world. Geriatrics often have multiple prescriptions and thus need to remember their dosages accurately. They may also suffer from memory disorders, making them unreliable in terms of sticking to their medication schedule. This has led to a growing number of medication management products coming into the market in recent years. The growing geriatric population in the U.S., Canada, and Western Europe is likely to be the major driver for the global medication management market over the forecast period. The growing geriatric population in Asia Pacific countries such as Japan, China, and India is also likely to be a key driver for the global medication management market over the forecast period.
Rising investment in healthcare IT is also likely to be a major driver for the global medication management market over the forecast period. Healthcare IT solutions have become increasingly important over the last few years, as data-driven decision making has become increasingly popular in the healthcare sector. On the other hand, the high costs of installing and maintaining medication management systems could constrict the market’s chances of further growth over the forecast period. 
Competitive Analysis:
Leading players in the global medication management market include Siemens Ltd., QuadraMed Affinity Corporation, Optum Inc., Omnicell Inc., Medical Information Technology Inc., McKesson Corporation, General Electric Company, and Allscripts Healthcare. 
In January 2020, Medisafe, a leading provider of medication management solutions, announced the inclusion of pharmacy services in its range of services. This includes the ability for patients to refill their prescriptions as well as having them delivered to their doorstep. 
Segmentation:
The global medication management market is segmented based on systems, services, mode of delivery, end user, and region.
By systems, the global market for medication management is segmented into computerized physician order entry systems, clinical decision support systems, administration software, inventory management systems, automated dispensing systems and assurance systems. The administration software segment is further classified as electronic medication administration records (eMAR) software and bar code medication administration (BCMA) software. The automated dispensing systems segment is further classified as centralized automated dispensing systems and decentralized automated dispensing systems (ADS); centralized automated dispensing system includes robots/robotic automated dispensing systems and carousels, while decentralized automated dispensing system (ADS) includes pharmacy-based decentralized automated dispensing systems, ward-based decentralized automated dispensing systems and automated unit-dose decentralized automated dispensing systems.
By services, the global medication management market is divided into point-of-care verification services and adverse drug effects (ADE) surveillance services.
By mode of delivery, the market is divided into web-based solutions, on-premise solutions, and cloud-based solutions.
Based on end user, the market is segmented into hospitals, pharmacies, and others.
Regional Analysis:
The global medication management market is dominated by North America, followed by Europe, due to the high prevalence of polypharmacy in the region and the presence of several leading healthcare players. Asia Pacific is likely to be the fastest growing regional market over the forecast period due to the growing healthcare sector in the region and the growing geriatric population. 
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

Updates 2020: Ligation Devices Market trends Moving toward 2024

Market research future will be publishing a Half cooked research report on “Global Ligation Devices Market trends ” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

News Update Hemophilia treatment drugs market Size, Trends Research and Reprot

Hemophilia refers to an inherited genetic blood disorder which affects the ability of the blood to clot due to the lack of a specific protein required for blood clotting. As per the analysis of Market Research Future (MRFR), the global hemophilia treatment market is likely to post a CAGR of 6.10% over the forecast period of 2018-2023. The global hemophilia treatment market was valued at USD 11,257.21 in 2017 and is due to reach a valuation of USD 16,059.17 by the end of 2023. 

The prevalence of hemophilia is found to be high across the globe, and it is in the backdrop of such high prevalence of hemophilia, the global hemophilia treatment drugs market is expanding steadily. The World Federation of Hemophilia estimates the number of people suffering from hemophilia in the US to be close to 17,000. 

An outlay of massive amounts by biotechnology companies and high government support for R&D activities has resulted in significant developments in recent years. Recombinant products have emerged as an alternative to plasma-derived products and consumers have demonstrated an increased inclination towards the use of recombinant products which can also be credited for the growth of the global hemophilia treatment market. Recombinant products, is derived from genetically engineered cells at are zero risks of contamination. 

On the downside, the market growth might be deterred by the high costs associated with hemophilia treatment which restricts the growth of the market in cost-sensitive markets. Hemophilia treatment involves a variety of technologically high-end products which limits the patient pool opting for treatment. 

Segmentation
The global hemophilia treatment market has been segmented based on type, treatment type, and end user. 

By type, the global hemophilia treatment market has been segmented into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment is the largest segment and is expected to reach a valuation of USD 12,697.99 at a CAGR of 6.23% by the end of the forecast period. 

By treatment type, the global hemophilia treatment market has been segmented into Plasma-derived coagulation factor concentrate, Recombinant coagulation factor concentrates, Desmopressin, Antifibrinolytic agents, and Gene Therapy. The recombinant coagulation factor concentrates segment is likely to expand at the highest CAGR of 7.01% over the forecast period. 

By end user, the global hemophilia treatment market has been segmented into hospitals & clinics, research organizations, and others. The hospitals & clinics segment accounted for the largest share of USD 7594.66 in 2017 and is also anticipated to showcase the fastest growth over the forecast period. 

Regional Analysis
Geographically, the global hemophilia treatment market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas account for the lion's share of the global hemophilia treatment market and is likely to maintain its lead over the forecast period. The growth of the Americas market can be attributed to the high occurrence of the disorder in the region coupled with growing expenditure on the healthcare sector. The presence of an established healthcare sector and towering support for R&D activities acts as a plus for the market growth. 

Europe holds the second largest share of the global hemophilia treatment market and exhibits similar growth pattern as that of the Americas. The Europe hemophilia treatment market is driven by high government support for research and development to develop advanced medical therapies. 

APAC is poised to showcase the highest growth rate of 8.38% over the forecast period. Prolific improvement in the healthcare sector coupled with high demand for advanced treatment options stimulates the growth of the APAC hemophilia treatment market. The presence of a large patient pool is also a co0ntributing factor. 

Competitive Landscape
The key players in the global hemophilia treatment market include F.Hoffmann-La Roche Ltd, Bayer AG, Baxter, Pfizer Inc, Sanofi, Novo Nordisk A/S, Shire, Kedrion, CSL Behring, Octapharma, Swedish Orphan Biovitrum AB, and Grifols International S.A. 


Posted by at No comments:
Labels:

Healthcare news: Global spirometry market 2020: Industry Forecast to 2023

Market Insights
According to the reports published by Market Research Future Reports, the global spirometry market is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests. 
Global Spirometry Market: Drivers & Trends
The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways. 
More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.
Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come. 
Segmental Overview
According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.
By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. 
By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.
By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring. 
Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Outlook
Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 
Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.
While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.
Key Players
In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)